PBE

Invesco Biotechnology & Genome ETF

PBE | AMEX
$102.33
-$1.13 (-1.09%)
At close: Oct 30, 2026, 3:59 PM ET
$102.38
+$0.05 (+0.05%)
After-hours: Oct 30, 2026, 3:28 PM ET
Total Holdings
34
Top 10 Holdings
43.74%
Top Sector
Healthcare (99.96%)

Sector Allocation

Healthcare
99.96%
Financial Services
0.04%
Cash & Others
0.00%
Symbol Name Price % Change Shares % Weight
VRTX
Vertex Pharmaceuticals Inc
- - 29.37K 4.97%
AMGN
Amgen Inc
- - 38.1K 4.83%
RPRX
Royalty Pharma PLC
- - 237.67K 4.68%
REGN
Regeneron Pharmaceuticals Inc
- - 20.17K 4.68%
BIIB
Biogen Inc
- - 66.3K 4.61%
ALNY
Alnylam Pharmaceuticals Inc
- - 43.32K 4.52%
GILD
Gilead Sciences Inc
- - 95.72K 4.34%
UTHR
United Therapeutics Corp
- - 22.13K 4.22%
TECH
Bio-Techne Corp
- - 145.56K 3.62%
VCEL
Vericel Corp
- - 199.66K 3.27%
CDNA
CareDx Inc
- - 324.15K 3.22%
PTGX
Protagonist Therapeutics Inc
- - 69.83K 3.20%
ILMN
Illumina Inc
- - 48.08K 3.19%
VCYT
Veracyte Inc
- - 157.93K 3.14%
PTCT
PTC Therapeutics Inc
- - 103.21K 3.06%
RGEN
Repligen Corp
- - 60.61K 3.05%
BCRX
BioCryst Pharmaceuticals Inc
- - 824.34K 3.01%
ACAD
ACADIA Pharmaceuticals Inc
- - 328.42K 3.00%
INCY
Incyte Corp
- - 71.91K 2.93%
-
QIAGEN NV
- - 196.46K 2.85%
Page 1 of 2

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.